SALICOR
Live / Allowed — Notice of allowance issued (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 28 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99110478
- Mark type
- Stylized text
- Filed
- 28 Mar 2025
- Published for opposition
- 23 Dec 2025
- Attorney of record
- ALI SHALCHI
Goods and services
- Class 005 — Pharmaceuticals: Prescription-only transdermal patches for the treatment of pain, namely, prescription transdermal patches featuring triethanolamine salicylate for pain relief sold exclusively to and through licensed healthcare professionals for in-practice or in-clinic dispensing and not for over-the-counter retail sale; none of the foregoing comprising medical dressings, disinfectants, diagnostic reagents or kits, or surgical apparatus or instruments
Owner
- Clinic Pharmaceuticals, LLC, Las Vegas, NV, US
- Clinic Pharmaceuticals, LLC, Las Vegas, NV, US
Prosecution history
- 17 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Dec 2025 — PUBLISHED FOR OPPOSITION
- 17 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Nov 2025 — EXAMINER'S AMENDMENT ENTERED
- 20 Nov 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 20 Nov 2025 — EXAMINERS AMENDMENT E-MAILED
- 20 Nov 2025 — EXAMINERS AMENDMENT -WRITTEN
- 18 Sept 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Sept 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Sept 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Sept 2025 — NON-FINAL ACTION E-MAILED
- 02 Sept 2025 — NON-FINAL ACTION WRITTEN